Global Axitinib Market Growth 2022-2028
- LP 4754765
- 78 Pages
- January 2022
- Pharmaceuticals
The United States Axitinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Axitinib market, reaching US$ million by the year 2028. As for the Europe Axitinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Axitinib players cover Pfizer, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Axitinib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Renal Cancer Treatment
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Axitinib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Axitinib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Axitinib by Country/Region, 2017, 2022 & 2028
2.2 Axitinib Segment by Type
2.2.1 Injection
2.2.2 Others
2.3 Axitinib Sales by Type
2.3.1 Global Axitinib Sales Market Share by Type (2017-2022)
2.3.2 Global Axitinib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Axitinib Sale Price by Type (2017-2022)
2.4 Axitinib Segment by Application
2.4.1 Renal Cancer Treatment
2.4.2 Others
2.5 Axitinib Sales by Application
2.5.1 Global Axitinib Sale Market Share by Application (2017-2022)
2.5.2 Global Axitinib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Axitinib Sale Price by Application (2017-2022)
3 Global Axitinib by Company
3.1 Global Axitinib Breakdown Data by Company
3.1.1 Global Axitinib Annual Sales by Company (2020-2022)
3.1.2 Global Axitinib Sales Market Share by Company (2020-2022)
3.2 Global Axitinib Annual Revenue by Company (2020-2022)
3.2.1 Global Axitinib Revenue by Company (2020-2022)
3.2.2 Global Axitinib Revenue Market Share by Company (2020-2022)
3.3 Global Axitinib Sale Price by Company
3.4 Key Manufacturers Axitinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Axitinib Product Location Distribution
3.4.2 Players Axitinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Axitinib by Geographic Region
4.1 World Historic Axitinib Market Size by Geographic Region (2017-2022)
4.1.1 Global Axitinib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Axitinib Annual Revenue by Geographic Region
4.2 World Historic Axitinib Market Size by Country/Region (2017-2022)
4.2.1 Global Axitinib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Axitinib Annual Revenue by Country/Region
4.3 Americas Axitinib Sales Growth
4.4 APAC Axitinib Sales Growth
4.5 Europe Axitinib Sales Growth
4.6 Middle East & Africa Axitinib Sales Growth
5 Americas
5.1 Americas Axitinib Sales by Country
5.1.1 Americas Axitinib Sales by Country (2017-2022)
5.1.2 Americas Axitinib Revenue by Country (2017-2022)
5.2 Americas Axitinib Sales by Type
5.3 Americas Axitinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Axitinib Sales by Region
6.1.1 APAC Axitinib Sales by Region (2017-2022)
6.1.2 APAC Axitinib Revenue by Region (2017-2022)
6.2 APAC Axitinib Sales by Type
6.3 APAC Axitinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Axitinib by Country
7.1.1 Europe Axitinib Sales by Country (2017-2022)
7.1.2 Europe Axitinib Revenue by Country (2017-2022)
7.2 Europe Axitinib Sales by Type
7.3 Europe Axitinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Axitinib by Country
8.1.1 Middle East & Africa Axitinib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Axitinib Revenue by Country (2017-2022)
8.2 Middle East & Africa Axitinib Sales by Type
8.3 Middle East & Africa Axitinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Axitinib
10.3 Manufacturing Process Analysis of Axitinib
10.4 Industry Chain Structure of Axitinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Axitinib Distributors
11.3 Axitinib Customer
12 World Forecast Review for Axitinib by Geographic Region
12.1 Global Axitinib Market Size Forecast by Region
12.1.1 Global Axitinib Forecast by Region (2023-2028)
12.1.2 Global Axitinib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Axitinib Forecast by Type
12.7 Global Axitinib Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Axitinib Product Offered
13.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Axitinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Axitinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Others
Table 5. Global Axitinib Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Axitinib Sales Market Share by Type (2017-2022)
Table 7. Global Axitinib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Axitinib Revenue Market Share by Type (2017-2022)
Table 9. Global Axitinib Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Axitinib Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Axitinib Sales Market Share by Application (2017-2022)
Table 12. Global Axitinib Revenue by Application (2017-2022)
Table 13. Global Axitinib Revenue Market Share by Application (2017-2022)
Table 14. Global Axitinib Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Axitinib Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Axitinib Sales Market Share by Company (2020-2022)
Table 17. Global Axitinib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Axitinib Revenue Market Share by Company (2020-2022)
Table 19. Global Axitinib Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Axitinib Producing Area Distribution and Sales Area
Table 21. Players Axitinib Products Offered
Table 22. Axitinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Axitinib Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Axitinib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Axitinib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Axitinib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Axitinib Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Axitinib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Axitinib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Axitinib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Axitinib Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Axitinib Sales Market Share by Country (2017-2022)
Table 35. Americas Axitinib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Axitinib Revenue Market Share by Country (2017-2022)
Table 37. Americas Axitinib Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Axitinib Sales Market Share by Type (2017-2022)
Table 39. Americas Axitinib Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Axitinib Sales Market Share by Application (2017-2022)
Table 41. APAC Axitinib Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Axitinib Sales Market Share by Region (2017-2022)
Table 43. APAC Axitinib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Axitinib Revenue Market Share by Region (2017-2022)
Table 45. APAC Axitinib Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Axitinib Sales Market Share by Type (2017-2022)
Table 47. APAC Axitinib Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Axitinib Sales Market Share by Application (2017-2022)
Table 49. Europe Axitinib Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Axitinib Sales Market Share by Country (2017-2022)
Table 51. Europe Axitinib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Axitinib Revenue Market Share by Country (2017-2022)
Table 53. Europe Axitinib Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Axitinib Sales Market Share by Type (2017-2022)
Table 55. Europe Axitinib Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Axitinib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Axitinib Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Axitinib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Axitinib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Axitinib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Axitinib Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Axitinib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Axitinib Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Axitinib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Axitinib
Table 66. Key Market Challenges & Risks of Axitinib
Table 67. Key Industry Trends of Axitinib
Table 68. Axitinib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Axitinib Distributors List
Table 71. Axitinib Customer List
Table 72. Global Axitinib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Axitinib Sales Market Forecast by Region
Table 74. Global Axitinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Axitinib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Axitinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Axitinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Axitinib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Axitinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Axitinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Axitinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Axitinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Axitinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Axitinib Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Axitinib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Axitinib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Axitinib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Axitinib Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Axitinib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Axitinib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Axitinib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Basic Information, Axitinib Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Axitinib Product Offered
Table 94. Pfizer Axitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Axitinib
Figure 2. Axitinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Axitinib Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Axitinib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Axitinib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Others
Figure 11. Global Axitinib Sales Market Share by Type in 2021
Figure 12. Global Axitinib Revenue Market Share by Type (2017-2022)
Figure 13. Axitinib Consumed in Renal Cancer Treatment
Figure 14. Global Axitinib Market: Renal Cancer Treatment (2017-2022) & (K Pcs)
Figure 15. Axitinib Consumed in Others
Figure 16. Global Axitinib Market: Others (2017-2022) & (K Pcs)
Figure 17. Global Axitinib Sales Market Share by Application (2017-2022)
Figure 18. Global Axitinib Revenue Market Share by Application in 2021
Figure 19. Axitinib Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Axitinib Revenue Market Share by Company in 2021
Figure 21. Global Axitinib Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Axitinib Revenue Market Share by Geographic Region in 2021
Figure 23. Global Axitinib Sales Market Share by Region (2017-2022)
Figure 24. Global Axitinib Revenue Market Share by Country/Region in 2021
Figure 25. Americas Axitinib Sales 2017-2022 (K Pcs)
Figure 26. Americas Axitinib Revenue 2017-2022 ($ Millions)
Figure 27. APAC Axitinib Sales 2017-2022 (K Pcs)
Figure 28. APAC Axitinib Revenue 2017-2022 ($ Millions)
Figure 29. Europe Axitinib Sales 2017-2022 (K Pcs)
Figure 30. Europe Axitinib Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Axitinib Sales 2017-2022 (K Pcs)
Figure 32. Middle East & Africa Axitinib Revenue 2017-2022 ($ Millions)
Figure 33. Americas Axitinib Sales Market Share by Country in 2021
Figure 34. Americas Axitinib Revenue Market Share by Country in 2021
Figure 35. United States Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Axitinib Sales Market Share by Region in 2021
Figure 40. APAC Axitinib Revenue Market Share by Regions in 2021
Figure 41. China Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Axitinib Sales Market Share by Country in 2021
Figure 48. Europe Axitinib Revenue Market Share by Country in 2021
Figure 49. Germany Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Axitinib Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Axitinib Revenue Market Share by Country in 2021
Figure 56. Egypt Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Axitinib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Axitinib in 2021
Figure 62. Manufacturing Process Analysis of Axitinib
Figure 63. Industry Chain Structure of Axitinib
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
